Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Specialized lipid profiles.

Karen E Friday1

  • 1Department of Endocrinology, Tulane University Health Sciences Center, 1430 Tulane Avenue, New Orleans, LA 70112, USA. fridayk@tulane.edu

Current Atherosclerosis Reports
|August 7, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful Retirement Planning for Endocrinologists.

Journal of the Endocrine Society·2024
Same author

A Comparison of Statin Therapies in Hypercholesterolemia in Women: A Subgroup Analysis of the STELLAR Study.

Journal of women's health (2002)·2015
Same author

Aggressive lipid management for cardiovascular prevention: evidence from clinical trials.

Experimental biology and medicine (Maywood, N.J.)·2003
Same journal

The Spectrum of Genetic Causes of Familial Hypercholesterolemia Phenotype.

Current atherosclerosis reports·2026
Same journal

Targeting LDL Across the Whole Spectrum of Chronic Kidney Disease: From Pathophysiology to Novel Treatments.

Current atherosclerosis reports·2026
Same journal

Overview of Novel Mechanisms in Obesity Pharmacotherapy and Implications for Cardiovascular Disease: A Narrative Review.

Current atherosclerosis reports·2026
Same journal

Artificial and Other Non-Nutritive Sweeteners, the Microbiome, and Cardiometabolic Health.

Current atherosclerosis reports·2026
Same journal

Single-cell Technologies in Atherosclerosis: Uncovering Cellular Heterogeneity, Mechanisms, and Therapeutic Opportunities.

Current atherosclerosis reports·2026
Same journal

Primary Prevention of Dyslipidemia: 10 Practice-Changing Takeaways from the 2026 ACC/AHA Multisociety Guideline.

Current atherosclerosis reports·2026
See all related articles

Accurate blood lipid and lipoprotein analysis is crucial for cardiovascular disease management. While newer methods exist, the Friedewald calculation for low-density lipoprotein (LDL) cholesterol remains the most common clinical laboratory test.

Area of Science:

  • Biochemistry
  • Clinical Chemistry
  • Cardiovascular Medicine

Background:

  • Abnormal blood lipids and lipoproteins significantly increase cardiovascular disease risk.
  • Effective management strategies necessitate precise clinical assessment of lipid profiles.
  • Lipoprotein analysis is vital for both patient care and scientific research.

Purpose of the Study:

  • To review current lipid and lipoprotein analysis methods.
  • To discuss the clinical utility of traditional and novel analytic techniques.
  • To highlight the current prevalence of different lipid testing methodologies.

Main Methods:

  • Discussion of traditional methods: Friedewald calculation for LDL cholesterol and ultracentrifugation.
  • Description of newer techniques: Vertical Auto Profile, NMR spectroscopy, direct LDL assays, LDL size, and triglyceride-rich lipoprotein remnants.

Related Experiment Videos

  • Analysis of current clinical laboratory practices for lipoprotein testing.

    • Main Results:

    • The Friedewald calculation for LDL cholesterol is used in approximately 93% of clinical laboratories.
    • A variety of traditional and advanced lipid and lipoprotein assays are available.
    • Widespread adoption of newer assays has not yet been established.

    Conclusions:

    • The Friedewald calculation remains the predominant method for LDL cholesterol assessment in clinical settings.
    • The future utilization of advanced lipid and lipoprotein assays requires further evaluation.
    • Continued assessment of lipid profiles is essential for optimizing cardiovascular disease prevention and treatment.